Background: Non-invasive tests can help with the diagnosis of Helicobacter pylori (H. pylori) infection and in determining patient prognosis following H. pylori eradication therapy. The aim of the study was to detect H. pylori antigens in the stool in symptomatic patients and to observe changes in the antigen test results following H. pylori eradication therapy. Methods: A prospective study was conducted. Blood, urine and stool samples were collected from 62 dyspeptic patients. Anti-H. pylori IgM and IgG antibodies were detected in the serum by ELISA, anti-H. pylori IgG antibodies were detected in the urine by ICT and H. pylori antigens were detected in the stool by ELISA. Among the 62 patients, 39 (62.90%) were positive with all three methods. These 39 patients were asked to complete a 2-week course of medication and return after 6 weeks following completion of therapy to undergo repeated tests. In total, 3 dropped out of the study. Results: Among the 62 dyspeptic patients, 41 (66.13%) were positive for serum IgG according to ELISA, 39 (62.90%) were positive for urine IgG according to ICT, 8 (12.90%) were positive for serum IgM according to ELISA, and 42 (67.74%) were positive for HpSA according to ELISA. After eradication therapy, 18 (50.00%) patients were positive for serum IgG, 19 (52.78%) were positive for urine IgG, 4 (11.11%) were positive for serum IgM and 5 (13.88%) were positive for HpSA. The difference in HpSA positivity before and after eradication therapy was statistically significant (P < 0.05). Conclusion: This study involved non-invasive procedures that can be used as first-line screening tools for the detection of active H. pylori infection to observe the role of HpSA test in diagnosis and assessment of prognosis following eradication therapy for H. pylori.
5 December 2024 in Bangladesh Journal of Medical Microbiology
Background: Acinetobacter baumannii infection treatment has become a clinical challenge due to the increasing resistance of the bacteria to different classes of antimicrobial agents and it needs to be identified before exposure to patients. Objective: This study aimed to determine the prevalence of Acinetobacter baumannii with its antibiotic-resistant patterns. Methodology: The study was a cross-sectional study that was done from 1st January 2019 to 31st December 2019 at the Microbiology Department of Dhaka Medical College. Clinical samples including endotracheal aspirates, blood, urine, sputum, wound swabs, and pus were collected from the patients from the intensive care unit, burn unit, general wards, and outpatient department of Dhaka Medical College and Hospital. Acinetobacter baumannii organisms were identified by biochemical tests and Gram staining, and the resistance pattern was determined by using the disc diffusion method for all antibiotics except for colistin, which was determined by minimum inhibitory concentration. Results: Among 500 clinical samples, 13.31% Acinetobacter baumannii were identified. Most of these showed resistance to fluoroquinolones, carbapenem, amikacin, the extended spectrum of cephalosporin, β-lactam, and β-lactamase inhibitors. However, the least resistant drug was tigecycline (8.88%). About 62.22% MDR, 28.89% A. baumannii were identified. Conclusion: Acinetobacter baumannii is showing increasing resistance to colistin and tigecycline. Bangladesh Journal of Medical Microbiology, January 2024;18(1):37-43
24 December 2024 in Journal of Global Antimicrobial Resistance
Klebsiella pneumoniae (Kpn), a WHO priority pathogen with high rates of antimicrobial resistance (AMR), has emerged as a leading cause of hospital acquired pneumonia and neonatal sepsis. We aimed to define the clinical characteristics of a cohort of patients with Kpn infection in Dhaka, Bangladesh and to perform phenotypic and genetic characterization of the associated isolates. We retrospectively extracted clinical data about patients at Dhaka Medical College Hospital from whom Klebsiella spp was isolated from a clinical specimen collected between February and September 2022. We used standard microbiologic techniques to evaluate AMR and whole-genome sequencing (WGS) to assess dominant lineages, common capsular (K) and O-polysaccharide (O) antigen types, and AMR and virulence genes. Ninety-eight patients were included, with diagnoses of pneumonia (38/98, 39 %), wound infection (29/98, 31 %), urinary tract infection (29/98, 31 %) and bacteremia (2/98, 2 %). We tested isolates for susceptibility to eight classes of antibiotics. Of the 98 isolates, 41 % were multidrug resistant (MDR), 15 % were extensively drug resistant (XDR), and 16 % were pan-drug resistant (PDR). Three isolates (3 %) were resistant to polymyxin B. Outcome data were available for 46 patients; 4 patients (8 %) died from infections caused by PDR (n = 2), XDR (n = 1), and MDR isolates (n = 1). WGS revealed a high degree of genomic diversity, with multiple sequence types (STs), O-types and K-types represented; ST16:K81:OL101 and ST43:K30:O1 were the most prevalent. Our findings suggest alarming levels of AMR among Kpn isolates in Bangladesh and a critical need for improved treatment modalities and vaccine development.
Background: Nosocomial infections have been discussed as a critical issue among intubated patients leading to significant morbidity and mortality. Tracheal colonization of different bacteria may be responsible for added or superinfections and may increase the risk of mortality. Irrational use of antibiotics also increases the emergence of drug-resistant bacteria. Objectives: We aimed to investigate the bacterial isolates in the endotracheal aspirates of ICU patients and to see the pattern of antibiotic susceptibility. Materials and Methods: This cross-sectional study was based on 40 specimens of endotracheal aspirates which were collected from ICU patients of Dhaka Medical College Hospital. All the specimens were processed and cultured on MacConkey and blood agar media. The isolated organisms were identified by different biochemical tests. Results: Among the 40 specimens, 38 (95%) yielded growths of different bacteria. Of them, Acinetobacter baumanni were 13 (34%), Pseudomonas aeruginosa were 6 (16%), Klebsiella pneumoniae were 3 (8%), Klebsiella oxytoca were 3 (8%) and Staphylococcus aureus were 3 (8%). All the isolated bacteria were sensitive to colistin and most of the Acinetobacter baumanni were resistant to different antibiotics. Among the 32 isolated gram-negative bacteria, 10 (31.25%) were ESBL producers. Conclusion: Most of the bacteria showed antibiotic resistance to different common antibiotics, which is very alarming for the ICU patients. J Enam Med Col 2018; 8(2): 67-73
9 December 2024 in Bangladesh Journal of Medical Microbiology
Background: Multi-drug-resistant (MDR) strains of Enterobacter cloacae are becoming increasingly prevalent worldwide, which is reducing treatment options. Objective: The purpose of the present study was to evaluate protective antibody response following vaccination with formaldehyde inactivated Enterobacter cloacae. Methodology: The study used formaldehyde inactivated MDR Enterobacter cloacae obtained from various clinical samples to immunize 10 Swiss albino mice through intradermal injection. After the third dose of immunization, the mice were challenged with live Enterobacter cloacae through intraperitoneal injection and were monitored for 14 days. Blood was collected from the tail 7 days after each booster and through cardiac puncture 14 days after the challenge. The serum antibody produced by the vaccine was evaluated for bactericidal activity and antigen-binding capacity using ELISA. Results: In this study, it was observed that 100% of the immunized mice survived after 14 days of challenge. The ELISA showed that all the immunized mouse sera had 100% bactericidal activity. Additionally, all the pre- and post-challenge immunized serum immunoglobulin G antibodies had significantly higher optical density values compared to the control mice in ELISA. Top of Form Conclusion: Our study showed that when formaldehyde inactivated MDR Enterobacter cloacae was used for intradermal immunization in Swiss albino mice, it produced antibodies that offered protection. Using a first-generation vaccine can provide a larger pool of antigens to elicit the desired immune response. Bangladesh Journal of Medical Microbiology, January 2024;18(1):44-49